SC
VIE

Steven Cohen’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Steven Cohen’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-127,983
Closed -$5.54M – 1172
2020
Q2 		$5.54M Buy
+127,983
New +$5.8M 0.04% 465

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Steven Cohen's VIE Position: Q3 2020 in Review

Steven Cohen sold out of Viela Bio, Inc. Common Stock (VIE) in Q3 2020, closing a stake of 127,983 shares — an estimated $5.54M sold.

Steven Cohen first reported a position in VIE in Q2 2020 and held it in 1 quarter. The position peaked at $5.54M in Q2 2020. 60 funds tracked by Wall St. Rank hold VIE as of Q3 2020.

  • Steven Cohen reported no remaining Viela Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Steven Cohen sold 127,983 Viela Bio, Inc. Common Stock shares in Q3 2020, an estimated $5.54M.
  • Steven Cohen first reported a position in Viela Bio, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Steven Cohen's Viela Bio, Inc. Common Stock position peaked at $5.54M in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q3 2020.

Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.